Kawasaki Disease (new) Flashcards

1
Q

Kawasaki Disease is also called:

A

Mucocutaneous Lymph Node Syndrome or
Infantile Polyarteritis Nodosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

● An acute febrile illness in childhood, seen worldwide especially in Asian children.
● This was first discovered in Japan.

A

KD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a systemic inflammatory disorder manifesting as vasculitis with a predilection for the coronary arteries?

A

KD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Those with KD, 20-25% of untreated children develop what?

A

coronary artery
abnormalities (CAA) including aneurysms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

<5% of children treated with this develop CAA

A

IVIg (Intravenous immune
globulin) develop CAA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the leading cause of acquired heart disease in children?

A

KD

● If there is a progression of the Kawasaki disease, there will be mild transient dilatation in the tunica intima and media which usually resolves in 4-6 weeks, but for those <5% treated, they would still progress into aneurysms and CAAs.
● They will have subacute/ chronic vasculitis, luminal
myofibroblastic proliferation, and laminar nonocclusive thrombosis.
● If there is further progression with atherosclerotic risk factors, then calcification will happen which hardens the arteries, resulting in complex stenosis which leads to ischemic heart disease and myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Etiology of KD

A

● Etiology is unknown
○ There are certain epidemiologic and clinical features that support an infectious origin although no single infectious agent is identified.
○ Usually if you ask these patients with Kawasaki disease, they would have mild fever weeks prior, cough, and colds coming from viral infections but at the end they cannot pinpoint the infectious origin.
● Genetic (polymorphism is the ITPKC gene, a T-cell regular)
● Higher in boys
● <5 years old
○ Rare if you catch Kawasaki disease in children more than 5 years old.
○ In younger children it is also quite difficult. That’s why we have another criteria for that one because for those who are less than 6 months old, they don’t
usually fulfill the criteria for Kawasaki disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

● vasculitis that predominantly affects the medium-size arteries; while other areas include: axillary, subclavian, femoral, popliteal, and brachial arteries.
● There are phases in regards to your Kawasaki disease.

What are these phases?

A

1st phase
● 1st 2 weeks.
● neutrophilic necrotizing arteritis that begins in the endothelium and moves through the coronary wall.
Saccular aneurysms may form from this arteritis.

2nd phase
● Weeks to years.
● subacute/chronic vasculitis driven by lymphocytes, plasma cells, and eosinophils, which may result in fusiform aneurysms.

3rd phase
● affected by the subacute/chronic vasculitis then develop smooth muscle cell myofibroblasts, which cause progressive stenosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical Manifestations of KD

A

● Fever (>38C) not responsive to antipyretics; if w/o treatment lasts 1-2 weeks.
● Most of the viral infections or bacterial infections are when you give antipyretics, initially there is a little resolution but
after an hour of giving your antipyretics some of the viral or bacterial infections will increase again.
● Others would have GI and respiratory symptoms
● Clinical features that are not consistent with KD include exudative conjunctivitis, exudative pharyngitis, generalized lymphadenopathy
● Discrete oral lesions (ulceration or exudative pharyngitis), splenomegaly, and bullous, petechial, or vesicular rashes.
● Myocarditis: tachycardia disproportionate to fever, with diminished left ventricular systolic function
● KD present in cardiogenic shock (KD shock syndrome), with greatly diminished left ventricular function
● Pericarditis with a small pericardial effusion
● Mitral regurgitation of at least mild severity is evident on echocardiography in 10-25% of patients at presentation but diminishes over time, except among rare patients with coronary aneurysms and ischemic heart disease.
● Coronary Artery Abnormalities develops in 25% on 2nd-3rd week and are usually asymptomatic
● Large giant aneurysms are at greatest risk of thrombosis or stenosis, angina, and myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical phases

A

Acute Febrile: fever and other acute signs of illness and usually lasts 1-2 weeks

Subacute Phase: desquamation, thrombocytosis development of CAA, and the highest risk of sudden death in patients who develop aneurysms; it generally lasts 3 weeks.

Convalescent Phase: clinical signs of illness have
disappeared and continue until the erythrocyte sedimentation
rate (ESR) returns to normal, typically 6-8 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CLASSIC CLINICAL CRITERIA

A

Fever persisting for at least 3 days

Pus

At least 4 of the following principle features
○ Extremity Changes - Erythema of palms soles, edema of hands/feet, periungual peeling of fingers, toes in 2-3 weeks
○ Rash - Polymorphous exanthema, NOT
bullous/vesicular
○ Changes in lips and oral cavity - Erythema, cracked lips, strawberry tongue, diffuse injection of oral and pharyngeal mucosa
○ Conjunctival injection - Bilateral, bulbur sparing limbus, non-purulent
○ Cervical lymphadenopathy >1.5 cm in diameter, most of the time its bilateral, but some of them can have unilateral lymphadenopathy

Supplemental laboratory criteria
○ Hypoalbuminemia - <3.0 mg/dL
○ Alanine aminotransferase (ALT) - Elevation above reference range (varies by laboratory)
○ Anemia for age - Decreased in hemoglobin before reference range for age
○ Leukocytosis - White blood cells >15,000/mm3
○ Sterile pyuria (urinalysis) - ≥ 10 WBC/HPF (high power field); no bacterial infection when culture is done
○ Thrombocytosis after 7 days - Platelets >
450,000/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Laboratory for KD

A

● NO DIAGNOSTIC TEST FOR KD.
● WBC elevated (neutrophilic predominance)
● Normocytic normochromic anemia
● Platelet: 1st week Normal; 2-3rd week >1M
● ESR and CRP elevated
● Sterile (pyuria)
● Diagnosis of KD leads to 2D echo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2D ECHO

A

● Coronary artery dimensions, adjusted for BSA (z scores), may be increased in the 1st few weeks

● The AHA z-score classification system is as follows:
No involvement: always < 2
Dilation only: 2 to <2.5; or initially <2, a decrease in z score during follow-up >= 1
Small aneurysm: >=2.5 to <5
Medium aneurysm: >=5 to <10 , and absolute dimension <8 mm
Large or giant aneurysm: >=10, or absolute dimension >=8 mm

● Echocardiography
○ At diagnosis and again after 1-2 weeks; if normal: 6-8 weeks after
○ If with abnormalities: more frequent

● So again your clinical diagnosis of fever of at least 4 days and at least 4 of the 5 principles characteristic of the illness and the diagnosis of Kawasaki’s disease should be made in 10 days and ideally within 7 days of fever onset to improve coronary outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DDx

A

● Usually viral infections such as adenoviruses, measles, and scarlet fever
○ Each has different types of rash
○ Usually nonspecific
○ Conjunctival injections, lymph nodes,
○ For measles, take note of the 3 Cs
■ Conjunctivitis, cough, and coryza
■ Also lymphadenopathy
■ In roseola, it starts with the trunk
■ But in measles, it usually starts in the head then progresses down then ends with the extremities
● In Kawasaki’s diseases, it appears in any part of the body
● In scarlet fever, it is typical with “slapped cheek” appearance and rashes
○ “Sand paper” feel on the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DIAGNOSIS: ATYPICAL OR INCOMPLETE
KAWASAKI’S DISEASE

A

● Mostly seen in infants (highest likelihood to have CAA)
● Patients have persistent fever but <4 of the 5 characteristic clinical signs
● Lab 2D echo assist in the diagnosis
○ Must fulfill 3 of the 5 clinical characteristic signs
● Is recommended that any infant age <=6 months with fever for >=7 days without explanation undergo echocardiography to assess the coronary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sample case:

A

● “Child with fever of more than 5 days and 2 or 3 clinical criteria of KD OR infant with fever of more than 7 days without other explanations.”
● Assess Laboratory Criteria
○ CRP <3.0 mg/dL and CSR<40 mm/H
■ Serial clinical and laboratory re-evaluations if
fevers persist
■ 2D echo if typical peeling peeling (under nails
beds of fingers/toes) occurs
○ CRP >3,0 mg/dL and/or CSR >40 mm/H
■ 3 or more laboratory findings
■ Anemia for age
■ Platelet count >450,000 after 7th day of fever
■ Albumin < 3.0g/dL
■ Elevated ALT
■ WBC > 15,000/mm
■ Urine > 10 WBC/hpf
■ Z score lf LAD or RCA > 2.5
■ Coronary artery aneurysm
■ >3 of the following suggestive features: decreased
LV function, mitral regurgitation, pericardial
effusion, Z score of LAD or RCA of 2 - 2.5

17
Q

DIFFERENTIAL DIAGNOSIS OF KAWASAKI DISEASE

A

Viral Infections
● Adenovirus, measles, and scarlet fever
● Systemic-onset juvenile idiopathic arthritis (sJIA) is also characterized by fever and rash, but physical findings include diffuse lymphadenopathy and hepatosplenomegaly

Systemic-onset juvenile idiopathic arthritis (sJIA)
● Systemic-onset juvenile idiopathic arthritis (sJIA) is also characterized by fever and rash, but physical findings include diffuse lymphadenopathy and
hepatosplenomegaly.
MANIFESTATIONS:
○ Eye pain, redness and blurred vision
○ Skin rashes
○ Weight loss
○ Joint swelling
○ Recurrent fever
○ Irritability and tiredness
○ Joint stiffness
○ Joint pain and tenderness (in any involve part)
■ If you catch the joint pains, its most likely sJIA

18
Q

Treatment for KD

A

● With 2 g/kg of IVIG as a single infusion, usually administered over 10-12 hr within 10 days of disease onset, and ideally as soon as possible after diagnosis.
○ You can still give your IVIG after 10 days, but then again, you already have your coronary abnormalities.
○ Ideally, as soon as possible after diagnosis.
○ Your IVIG is very expensive. If the patient is obese, they would really have difficulty.
■ If you have a 10 kg child, you’d need 20 g (that would be around 80,000-100,000 pesos)

○ SIDE EFFECTS:
■ Fever
■ headache (especially if it’s infused quickly) – that is why the treatment of your Kawasaki disease is given 10-12 hours via infusion
● Initially, the patient is given the starting dose of 5 cc and slowly increase until you reach the maximum volume to be infused
○ While procuring IVIG for a Kawasaki patient, you start your aspirin because it could also lyse the fever
○ Start moderate to high dose of aspirin
● Moderate (30-50 mg/kg/day divided every 6 hr) to high-dose aspirin (80-100 mg/kg/day divided every 6 hr) should be administered until the patient is afebrile
○ Once the patient is afebrile for 24-48 hours you can discontinue your moderate to high dose of aspirin
● Then lowered to antiplatelet doses dose of aspirin is usually (3-5 mg/kg/day as a single dose) after the patient has been afebrile for 48 hr
● NSAID should not be given during therapy with aspirin because they may block the action of aspirin
○ Usually, you just give paracetamol for fever
○ Ibuprofen is avoided, especially in the Philippines where there are high cases of Dengue, since it could cause the platelets to decrease putting the patients at risk if they have Dengue
● After 12 hours from the last IVIG infusion, the fever will disappear
● IVIG-resistant KD: persistent or recrudescent fever 36 hr.
After completion of the initial IVIG infusion
● 2nd dose of IVIG (2g/kg), a tapering course of corticosteroids, and/or infliximab

19
Q

Complications

A

● Aneurysms may experience myocardial infarction, angina, and sudden death
○ Some would present stroke
○ on second week of illness—have fever
○ Sudden death
● Aspirin is continued indefinitely in children with coronary aneurysms
● When aneurysms are moderate sized, dual-antiplatelet therapy is sometimes administered
● For those with large or giant aneurysms, anticoagulation with warfarin or low molecular-weight heparin is added to aspirin (injection form)
● For acute thrombosis that occasionally occurs in an aneurysmal or stenotic coronary artery, thrombolytic therapy may be lifesaving
● Long term follow up of patients with coronary artery aneurysms
○ Cardiologist manage these patients

20
Q

Prognosis

A

● The vast majority of patients with KD return to normal health
● Timely treatment reduces the risk of coronary aneurysms
to <5%